Rapid communication: insights into the role of extracellular vesicles during Auger radioimmunotherapy-Reference-Cited by-同舟云学术

Rapid communication: insights into the role of extracellular vesicles during Auger radioimmunotherapy

Published:2021-07-26 Issue: Volume: Page:1-10
ISSN:0955-3002
Container-title:International Journal of Radiation Biology
language:en
Short-container-title:International Journal of Radiation Biology

Author:

Karam Jihad¹^ORCID,Constanzo Julie¹,Pichard Alexandre¹,Gros Laurent¹,Chopineau Joël²,Morille Marie²,Pouget Jean-Pierre¹

Affiliation:

1. Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Institut Régional du Cancer de Montpellier (ICM), Université de Montpellier, Montpellier, France

2. ICGM, ENSCM, CNRS, Université de Montpellier, Montpellier, France

Funder

SIRIC Montpellier Cancer

French National Research Agency as part of the Investissements d'Avenir

Cancéropôle Grand Sud Ouest

fondation ARC pour la recherche sur le cancer

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09553002.2021.1955999

Reference40 articles.

1. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons

2. The non-targeted effects of radiation are perpetuated by exosomes

3. Complex cell geometry and sources distribution model for Monte Carlo single cell dosimetry with iodine 125 radioimmunotherapy

4. Direct evidence for a bystander effect of ionizing radiation in primary human fibroblasts

5. Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Treatment of Various Cancers using Radionuclide: Advancement and Prospective;Current Cancer Therapy Reviews;2024-05-31

2. Immunological effects of radiopharmaceutical therapy;Frontiers in Nuclear Medicine;2024-04-04

3. Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors;Trends in Cancer;2023-11

4. Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy;Journal of Nuclear Medicine;2023-10-19

5. Immunomodulatory effects of targeted radionuclide therapy;International Review of Cell and Molecular Biology;2023